Not kidding at all. I think we can respect the work of a company and it's management, while seeing room for improvement. HotCopper these days seems to be full of people who are very quick to shout down opposing view points.
Many of the recent investor presentations before this have been recycled slides.
I think until today we have very much undercommunicated the clinical and commerical successes of Acadia's launch of Trofinetide in the US. Although this is primarily Acadia's responsibility, this launch is responsible for >99% of our non ROW milestone revenue.
As I've pointed out in other posts, many people in the healthcare industry, media, health regulators have no idea who we are. Our value is only what others are willing to pay for it.
NEU Price at posting:
$12.06 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)